Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

NCT00453063 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: mometasone furoate
DRUG: Placebo

Sponsor

Organon and Co